Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
Crossref DOI link: https://doi.org/10.1007/s40291-023-00643-4
Published Online: 2023-03-04
Published Print: 2023-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cammett, Tobin J
Garlo, Katherine
Millman, Ellen E
Rice, Kara
Toste, Catherine M
Faas, Susan J.
Text and Data Mining valid from 2023-03-01
Version of Record valid from 2023-03-04
Article History
Accepted: 7 February 2023
First Online: 4 March 2023